Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2019, Vol. 48 Issue (3): 342-346    DOI: 10.3785/j.issn.1008-9292.2019.06.16
会议亮点     
粪菌移植的研究现状与展望
胡玥(),吕宾*()
浙江中医药大学附属第一医院消化科 浙江省消化道疾病病理生理研究重点实验室, 浙江 杭州 310006
Development and prospects of fecal microbiota transplantation
HU Yue(),LYU Bin*()
Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310006, China
 全文: PDF(889 KB)   HTML( 15 )
关键词： 肠/微生物学;  粪便微生物群移植;  梭菌, 难辨;  结肠炎, 溃疡性;  肠易激综合征;  抗药性, 多药;  肥胖症;  会议    
Key words: Intestines/microbiology    Fecal microbiota transplantation    Clostridium difficile    Colitis, ulcerative    Irritable bowel syndrome    Drug resistance, multiple    Obesity    Congresses
收稿日期: 2019-06-02 出版日期: 2019-09-04
CLC:  R574  
基金资助: 国家自然科学基金(81770535)
通讯作者: 吕宾     E-mail: huyue@zcmu.edu.cn;lvbin@medmail.com.cn
作者简介: 胡玥(1989-), 女, 博士, 住院医师, 主要从事肠易激综合征免疫和微生态基础研究; E-mail:huyue@zcmu.edu.cn; https://orcid.org/0000-0001-5346-0164
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
胡玥
吕宾

引用本文:

胡玥, 吕宾. 粪菌移植的研究现状与展望[J]. 浙江大学学报（医学版）, 2019, 48(3): 342-346.

HU Yue, LYU Bin. Development and prospects of fecal microbiota transplantation. J Zhejiang Univ (Med Sci), 2019, 48(3): 342-346.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.06.16    或    http://www.zjujournals.com/med/CN/Y2019/V48/I3/342

1 GUPTA A , KHANNA S . Fecal microbiota transplantation[J]. JAMA, 2017, 318 (1): 102
doi: 10.1001/jama.2017.6466
2 VINDIGNI S M , SURAWICZ C M . Fecal microbiota transplantation[J]. Gastroenterol Clin North Am, 2017, 46 (1): 171- 185
doi: 10.1016/j.gtc.2016.09.012
3 LYNCH S V , PEDERSEN O . The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375 (24): 2369- 2379
doi: 10.1056/NEJMra1600266
4 HE Z , LI P , ZHU J et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass[J]. Sci Rep, 2017, 7 (1): 4753
doi: 10.1038/s41598-017-04984-z
5 ROSSEN N G , FUENTES S , VAN DER SPEK M J et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis[J]. Gastroenterology, 2015, 149 (1): 110- 118
doi: 10.1053/j.gastro.2015.03.045
6 PARAMSOTHY S , KAMM M A , KAAKOUSH N O et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis:a randomised placebo-controlled trial[J]. Lancet, 2017, 389 (10075): 1218- 1228
doi: 10.1016/S0140-6736(17)30182-4
7 JOHNSEN P H , HILPVSCH F , CAVANAGH J P et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome:a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[J]. Lancet Gastroenterol Hepatol, 2018, 3 (1): 17- 24
doi: 10.1016/S2468-1253(17)30338-2
8 TIAN H , DING C , GONG J et al. Treatment of slow transit constipation with fecal microbiota transplantation:a pilot study[J]. J Clin Gastroenterol, 2016, 50 (10): 865- 870
doi: 10.1097/MCG.0000000000000472
9 REN Y D , YE Z S , YANG L Z et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy[J]. Hepatology, 2017, 65 (5): 1765- 1768
doi: 10.1002/hep.29008
10 BAJAJ J S , KASSAM Z , FAGAN A et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy:a randomized clinical trial[J]. Hepatology, 2017, 66 (6): 1727- 1738
doi: 10.1002/hep.29306
11 VRIEZE A , VAN NOOD E , HOLLEMAN F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143 (4): 913- 6
doi: 10.1053/j.gastro.2012.06.031
12 KAKIHANA K , FUJIOKA Y , SUDA W et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut[J]. Blood, 2016, 128 (16): 2083- 2088
doi: 10.1182/blood-2016-05-717652
13 HE Z , CUI B T , ZHANG T et al. Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease:The first report[J]. World J Gastroenterol, 2017, 23 (19): 3565- 3568
doi: 10.3748/wjg.v23.i19.3565
14 SURAWICZ C M , BRANDT L J , BINION D G et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections[J]. Am J Gastroenterol, 2013, 108 (4): 478- 498
doi: 10.1038/ajg.2013.4
15 MULLISH B H , QURAISHI M N , SEGAL J P et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications:joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines[J]. Gut, 2018, 67 (11): 1920- 1941
doi: 10.1136/gutjnl-2018-316818
16 MCDONALD L C , GERDING D N , JOHNSON S et al. Clinical practice guidelines for clostridium difficile infection in adults and children:2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J]. Clin Infect Dis, 2018, 66 (7): 987- 994
doi: 10.1093/cid/ciy149
17 SINGH S , FEUERSTEIN J D , BINION D G et al. AGA technical review on the management of mild-to-moderate ulcerative colitis[J]. Gastroenterology, 2019, 156 (3): 769- 808
doi: 10.1053/j.gastro.2018.12.008
18 MOAYYEDI P , SURETTE M G , KIM P T et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial[J]. Gastroenterology, 2015, 149 (1): 102- 109
doi: 10.1053/j.gastro.2015.04.001
19 KASSINEN A , KROGIUS-KURIKKA L , M?KIVUOKKO H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects[J]. Gastroenterology, 2007, 133 (1): 24- 33
doi: 10.1053/j.gastro.2007.04.005
20 BHATTARAI Y , MUNIZ PEDROGO D A , KASHYAP P C . Irritable bowel syndrome:a gut microbiota-related disorder?[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312 (1): G52- G62
doi: 10.1152/ajpgi.00338.2016
21 XU D , CHEN V L , STEINER C A et al. Efficacy of fecal microbiota transplantation in irritable bowel syndrome:a systematic review and meta-analysis[J]. Am J Gastroenterol, 2019, 114 (7): 1043- 1050
doi: 10.14309/ajg.0000000000000198
[1] 杨林东,包芳,吴元赭,孙丽洲. 晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析[J]. 浙江大学学报（医学版）, 2020, 49(3): 389-396.
[2] 范一宏, 吕宾. 炎性肠疾病研究前沿[J]. 浙江大学学报（医学版）, 2019, 48(3): 334-341.
[3] 戚小华,王心怡,何凡,刘碧瑶,章涛,李傅冬,翟羽佳,林君芬. 大型活动期间举办地外围地区突发传染病事件公共卫生风险评估[J]. 浙江大学学报（医学版）, 2018, 47(2): 124-130.
[4] 郑琪,卢美萍. 儿童风湿免疫性疾病研究热点[J]. 浙江大学学报（医学版）, 2018, 47(2): 213-217.
[5] 卢伸,王青青. 第14届国际树突状细胞会议热点解读[J]. 浙江大学学报（医学版）, 2017, 46(1): 106-109.
[6] 陈飞等. 2015年世界胃肠病组织国际会议和欧洲消化疾病周热点[J]. 浙江大学学报（医学版）, 2015, 44(6): 703-706.
[7] 韦洁平, 黄河. 第19届亚太国际造血干细胞移植会议热点[J]. 浙江大学学报（医学版）, 2015, 44(1): 112-115.
[8] 陈新华, 张雪明, 殷胜勇, 郑树森. 生物电技术与肿瘤微创治疗研究进展——来自第11届国际生物电年会[J]. 浙江大学学报（医学版）, 2015, 44(1): 108-111.
[9] 王侃，等. 美国胃肠病协会首届中国学术论坛精要[J]. 浙江大学学报（医学版）, 2014, 43(6): 728-730.
[10] 陈联辉，梁黎，傅君芬，朱伟芬，王春林，黄轲，方燕兰，陈雪峰. 两种儿童青少年代谢综合征定义的临床应用比较[J]. 浙江大学学报（医学版）, 2013, 42(4): 375-.
[11] 林胡，傅君芬，陈雪峰，黄轲，吴蔚，梁黎. 肥胖儿童青少年非酒精性脂肪肝病早期肾功能状况研究[J]. 浙江大学学报（医学版）, 2013, 42(4): 381-.
[12] 朱铭强，傅君芬，梁黎，巩纯秀，熊丰，刘戈力，罗飞宏，陈少科. 中国儿童青少年性发育现状研究[J]. 浙江大学学报（医学版）, 2013, 42(4): 396-.
[13] . 应用抑制性消减杂交技术筛选脂肪细胞分化相关基因[J]. 浙江大学学报（医学版）, 2012, 41(3): 267-273.
[14] . 尼克酰胺磷酸核糖转移酶与衰老及衰老相关疾病研究进展[J]. 浙江大学学报（医学版）, 2011, 40(6): 680-684.
[15] . 信函和会议两种形式Delphi专家咨询的效果评价[J]. 浙江大学学报（医学版）, 2011, 40(3): 276-280.